As it turns out, your probiotic could pack a bigger punch than you realize.
Total net revenue of $15.2 million Adjusted EBITDA1 of $ (0.8) million, which includes EXXUA launch investments $30.0 million cash balance at December 31, 2025 Company launched EXXUA™ (gepirone) ...
TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyUnique sublingual formulation ...
WhiteSands Alcohol & Drug Rehab Orlando has published a new educational resource focused on treatment considerations during ...
Some common dietary supplements can raise blood pressure, especially if you already have high blood pressure or heart ...
Otsuka Pharmaceutical announced that the FDA is reviewing investigational centanafadine -- a potential first-in-class ...
The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...
FDA fast tracks ADHD drug centanafadine, targeting approval by July 24 for treatment across all age groups, based on phase 3 trial results.
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates.
Saffron is a spice that’s been used in cooking for thousands of years, but it’s popping up all over social media in recent ...
Many species of fungus across the world produce psilocybin, a chemical with psychedelic effects in humans, but its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results